CJC-1295 DAC Peptide Vial 5mg Lyophilisate For Lab Research

What is CJC-1295 DAC?

CJC-1295 DAC is a synthetic analogue of growth hormone-releasing hormone (GHRH) modified with a Drug Affinity Complex (DAC) technology. This modification enables the peptide to bind to serum albumin in the bloodstream, dramatically extending its half-life compared to native GHRH. The result is a long-acting GHRH analogue that provides sustained stimulation of growth hormone secretion, making it a valuable tool in endocrinology and metabolic research.

Key Research Areas

• Growth Hormone Research — Stimulates sustained pulsatile GH release via GHRH receptor activation, studied in endocrine models
• Extended Half-Life Studies — DAC technology enables albumin binding, prolonging activity for long-duration research protocols
• Muscle & Body Composition Research — Investigated for its effects on lean mass, fat metabolism and anabolic signalling pathways
• IGF-1 Axis Research — Studied for its downstream effects on insulin-like growth factor-1 (IGF-1) production
• Anti-Aging & Metabolic Models — Explored for its role in age-related decline of GH secretion and metabolic function

Product Details

• Quantity: 5mg per vial
• Form: Lyophilisate (lyophilized powder)
• Intended for research purposes only